OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey
Derya Çağlayan, Ahmet Furkan SÜNER, Neslişah Şiyve, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2212-2221
Open Access | Times Cited: 44
Derya Çağlayan, Ahmet Furkan SÜNER, Neslişah Şiyve, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2212-2221
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10752-10752
Open Access | Times Cited: 35
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10752-10752
Open Access | Times Cited: 35
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
Zsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 539-539
Open Access | Times Cited: 32
Zsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 539-539
Open Access | Times Cited: 32
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 5
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 5
Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers
Irmak Güzel, Gamze ÖZTÜRK, Özgür Appak, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Irmak Güzel, Gamze ÖZTÜRK, Özgür Appak, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers
Watsamon Jantarabenjakul, Pimpayao Sodsai, Napaporn Chantasrisawad, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 639-639
Open Access | Times Cited: 21
Watsamon Jantarabenjakul, Pimpayao Sodsai, Napaporn Chantasrisawad, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 639-639
Open Access | Times Cited: 21
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
Maria Teresa Vietri, Giovanna D’Elia, Gemma Caliendo, et al.
Vaccine (2022) Vol. 40, Iss. 39, pp. 5726-5731
Open Access | Times Cited: 17
Maria Teresa Vietri, Giovanna D’Elia, Gemma Caliendo, et al.
Vaccine (2022) Vol. 40, Iss. 39, pp. 5726-5731
Open Access | Times Cited: 17
Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection
Miguel Hueda-Zavaleta, Juan Carlos Gómez de la Torre, José Alonso Cáceres-DelAguila, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 502-502
Open Access | Times Cited: 13
Miguel Hueda-Zavaleta, Juan Carlos Gómez de la Torre, José Alonso Cáceres-DelAguila, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 502-502
Open Access | Times Cited: 13
Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 13
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 13
Immunogenicity After a Heterologous BNT262b2 Versus Homologous Booster in Kidney Transplant Recipients Receiving 2 Doses of CoronaVac Vaccine: A Prospective Cohort Study
José Medina‐Pestana, Laila Almeida Viana, Mônica Rika Nakamura, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2076-2084
Open Access | Times Cited: 13
José Medina‐Pestana, Laila Almeida Viana, Mônica Rika Nakamura, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2076-2084
Open Access | Times Cited: 13
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Sabina Zurac, Cristian Vlădan, Octavian Dincă, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Sabina Zurac, Cristian Vlădan, Octavian Dincă, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia
Matthew Tze Jian Wong, Satvinder S. Dhaliwal, Venugopal Balakrishnan, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1647-1647
Open Access | Times Cited: 7
Matthew Tze Jian Wong, Satvinder S. Dhaliwal, Venugopal Balakrishnan, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1647-1647
Open Access | Times Cited: 7
Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs
Neşe Saltoğlu, Harika Öykü Dinç, İ̇lker İnanç Balkan, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 104, Iss. 2, pp. 115758-115758
Open Access | Times Cited: 10
Neşe Saltoğlu, Harika Öykü Dinç, İ̇lker İnanç Balkan, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 104, Iss. 2, pp. 115758-115758
Open Access | Times Cited: 10
Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
Hazal Cansu Çulpan, Sümeyye Nur Aydın, Abdulkerim Uygur, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
Hazal Cansu Çulpan, Sümeyye Nur Aydın, Abdulkerim Uygur, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
Antibody response to different COVID-19 vaccine regimes: a review
Tamires Cardoso Matsui, Amanda Campelo Lima de Melo, Maria da Conceição Rodrigues Fernandes, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 488-506
Open Access | Times Cited: 1
Tamires Cardoso Matsui, Amanda Campelo Lima de Melo, Maria da Conceição Rodrigues Fernandes, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 488-506
Open Access | Times Cited: 1
SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost
Olivera Lijeskić, Neda Bauman, Miloš Marković, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1665-1672
Closed Access | Times Cited: 1
Olivera Lijeskić, Neda Bauman, Miloš Marković, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1665-1672
Closed Access | Times Cited: 1
Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
Meli̇ha Çağla Sönmezer, Gülçin Telli Dizman, Enes Erul, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1140-1140
Open Access | Times Cited: 8
Meli̇ha Çağla Sönmezer, Gülçin Telli Dizman, Enes Erul, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1140-1140
Open Access | Times Cited: 8
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
Victoria Ward, Jia Wei, William Gordon, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e066766-e066766
Open Access | Times Cited: 8
Victoria Ward, Jia Wei, William Gordon, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e066766-e066766
Open Access | Times Cited: 8
Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
Uraporn Phumisantiphong, Sirichan Chunhakan, Anan Manomaipiboon, et al.
Vaccine X (2023) Vol. 13, pp. 100277-100277
Open Access | Times Cited: 4
Uraporn Phumisantiphong, Sirichan Chunhakan, Anan Manomaipiboon, et al.
Vaccine X (2023) Vol. 13, pp. 100277-100277
Open Access | Times Cited: 4
Differential Dynamics of Humoral and Cell-Mediated Immunity with Three Doses of BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers in Japan: A Prospective Cohort Study
Keita Yamashita, Akira Suzuki, Shiori Takebayashi, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1050-1050
Open Access | Times Cited: 7
Keita Yamashita, Akira Suzuki, Shiori Takebayashi, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1050-1050
Open Access | Times Cited: 7
Dynamics of Neutralizing Antibody and T-cell Responses to SARS-CoV-2 and Variants of Concern After Primary Immunization With CoronaVac and Booster With BNT162b2 or ChAdOx1 in Health Care Workers
Watsamon Jantarabenjakul, Pimpayao Sodsai, Napaporn Chantasrisawad, et al.
(2022)
Open Access | Times Cited: 6
Watsamon Jantarabenjakul, Pimpayao Sodsai, Napaporn Chantasrisawad, et al.
(2022)
Open Access | Times Cited: 6
The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study
Phey Liana, Zen Hafy, Soilia Fertilita, et al.
Vacunas (2023) Vol. 24, Iss. 4, pp. 273-277
Open Access | Times Cited: 3
Phey Liana, Zen Hafy, Soilia Fertilita, et al.
Vacunas (2023) Vol. 24, Iss. 4, pp. 273-277
Open Access | Times Cited: 3
Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers
Kübra Çiçek, Yunus Özkaya, Erhan Eser, et al.
Mikrobiyoloji Bulteni (2023) Vol. 57, Iss. 2, pp. 238-251
Open Access | Times Cited: 3
Kübra Çiçek, Yunus Özkaya, Erhan Eser, et al.
Mikrobiyoloji Bulteni (2023) Vol. 57, Iss. 2, pp. 238-251
Open Access | Times Cited: 3
Assessment of Antibody-Titer Changes after Second and Third Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination in Japanese Post-Kidney-Transplant Patients
Kumiko Fujieda, Akihito Tanaka, Ryosuke Kikuchi, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 134-134
Open Access | Times Cited: 2
Kumiko Fujieda, Akihito Tanaka, Ryosuke Kikuchi, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 134-134
Open Access | Times Cited: 2
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
